MYLAN 217 250 (Tolazamide 250 mg)
Pill imprint MYLAN 217 250 has been identified as Tolazamide 250 mg.
Tolazamide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Tolazamide 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 217 250 (Tolazamide 250 mg)
- 250 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
Tolazamide is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...